Cargando…

Differential effects of angiotensin II type I receptor blockers on reducing intraocular pressure and TGFβ signaling in the mouse retina

PURPOSE: Angiotensin II type 1 receptor blockers (ARBs) have been investigated for their neuroprotective and intraocular pressure (IOP) lowering effects in treating glaucoma, but the reports have been inconsistent possibly because different compounds and models have been used. Here we selected three...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hazlewood, Ralph J., Chen, Qingxia, Clark, Frances K., Kuchtey, John, Kuchtey, Rachel W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6084929/ https://www.ncbi.nlm.nih.gov/pubmed/30092004 http://dx.doi.org/10.1371/journal.pone.0201719

Ejemplares similares

Enlarged Optic Nerve Axons and Reduced Visual Function in Mice with Defective Microfibrils
por: Wu, Hang-Jing, et al.
Publicado: (2018)

Telmisartan Reduces Axon Degeneration in Mice With Experimental Glaucoma
por: Hazlewood, Ralph J., et al.
Publicado: (2020)

Severe open angle glaucoma in hereditary hemorrhagic telangiectasia
por: Kuchtey, Rachel W, et al.
Publicado: (2015)

Increased Susceptibility to Glaucomatous Damage in Microfibril Deficient Mice
por: Wu, Hang-Jing, et al.
Publicado: (2020)

Marfan Syndrome Caused by a Novel FBN1 Mutation With Associated Pigmentary Glaucoma
por: Kuchtey, John, et al.
Publicado: (2013)

Not too long, not too short: Goldilocks principle of eye size
por: Kuchtey, Rachel W.
Publicado: (2020)

Altered Ocular Fibrillin Microfibril Composition in Mice With a Glaucoma-Causing Mutation of Adamts10
por: Wu, Hang-Jing, et al.
Publicado: (2021)

Adamts10 controls transforming growth factor β family signaling that contributes to retinal ganglion cell development
por: Wareham, Lauren K., et al.
Publicado: (2022)

Lysyl oxidase-like 1 deficiency alters ultrastructural and biomechanical properties of the peripapillary sclera in mice
por: Wareham, Lauren K., et al.
Publicado: (2022)

Worsening angle closure glaucoma and choroidal detachments subsequent to closure of a carotid cavernous fistula
por: Thinda, Sumeer, et al.
Publicado: (2012)

Mapping of the Disease Locus and Identification of ADAMTS10 As a Candidate Gene in a Canine Model of Primary Open Angle Glaucoma
por: Kuchtey, John, et al.
Publicado: (2011)

Acute myopia and angle closure glaucoma from topiramate in a seven-year-old: a case report and review of the literature
por: Rapoport, Yuna, et al.
Publicado: (2014)

Visit-to-Visit Variability and Seasonal Variation in Blood Pressure With Single-Pill Fixed-Dose Combinations of Angiotensin II Receptor Blocker/Calcium Channel Blocker and Angiotensin II Receptor Blocker/Diuretic in Hypertensive Patients
por: Shiga, Yuhei, et al.
Publicado: (2015)

Calcium channel blockers, angiotensin receptor blockers, and angiotensin-converting enzyme inhibitors: Effectiveness in combination with diuretics or β-blockers for treating hypertension
por: Bisognano, John D, et al.
Publicado: (2007)

Angiotensin II Receptor Blockers and Arrhythmias in Ventricular Hypertrophy
por: Salama, Guy
Publicado: (2022)

Clinical Pharmacogenetics of Angiotensin II Receptor Blockers in Iraq
por: Al-Hussaniy, Hany A., et al.
Publicado: (2023)

The Fetal Safety of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers
por: Moretti, Myla E., et al.
Publicado: (2012)

Receptor Interactions of Angiotensin II and Angiotensin Receptor Blockers—Relevance to COVID-19
por: Moore, Graham J., et al.
Publicado: (2021)

Long-term intraocular pressure after switching a combination ophthalmic medication of β-blocker/prostaglandin
por: Takada, Yukihisa, et al.
Publicado: (2020)

Prediction of left ventricular reverse remodeling after therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and β blockers in patients with idiopathic dilated cardiomyopathy
por: Matsumura, Yoshihisa, et al.
Publicado: (2015)

Targeting effective blood pressure control with angiotensin receptor blockers
por: Asmar, R
Publicado: (2006)

Blood pressure‐independent inhibition of Marfan aortic root widening by the angiotensin II receptor blocker valsartan
por: Tehrani, Arash Y., et al.
Publicado: (2021)

Pneumonia Risk and Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers
por: Liu, Chia-Lin, et al.
Publicado: (2013)

Effect of angiotensin converting enzyme inhibitor and angiotensin II receptor blocker on the patients with sepsis
por: Lee, Hyun Woo, et al.
Publicado: (2021)

Fracture Risk and Use of Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers
por: Holloway-Kew, Kara L., et al.
Publicado: (2022)

Synaptophysin Expression in Rat Retina Following Acute High Intraocular Pressure
por: Dan, Chen, et al.
Publicado: (2008)

Spatiotemporal alterations of presynaptic elements in the retina after high intraocular pressure☆
por: Huang, Jufang, et al.
Publicado: (2012)

TGFβ-Neurotrophin Interactions in Heart, Retina, and Brain
por: Schlecht, Anja, et al.
Publicado: (2021)

Summertime dosage-dependent hypersensitivity to an angiotensin II receptor blocker
por: Forsdyke, Donald R
Publicado: (2015)

Adherence and optimization of angiotensin converting enzyme inhibitor/angiotensin II receptors blockers and beta‐blockers in patients hospitalized for acute heart failure
por: Carubelli, Valentina, et al.
Publicado: (2021)

Onset of Hyperkalemia following the Administration of Angiotensin-Converting Enzyme Inhibitor or Angiotensin II Receptor Blocker
por: Jun, Hye-Ran, et al.
Publicado: (2021)

Differential Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers on COVID-19
por: Su, Lianjiu, et al.
Publicado: (2021)

Usage of Angiotensin-Converting Enzyme Inhibitor or Angiotensin II Receptor Blocker in Hypertension Intracerebral Hemorrhage
por: Zhang, Chao, et al.
Publicado: (2021)

Effect of Topical Calcium Channel Blockers on Intraocular Pressure in Steroid-induced Glaucoma
por: Ganekal, Sunil, et al.
Publicado: (2014)

Amlodipine versus angiotensin II receptor blocker; control of blood pressure evaluation trial in diabetics (ADVANCED-J)
por: Kawamori, Ryuzo, et al.
Publicado: (2006)

Angiotensin Inhibition, TGF-β and EMT in Cancer
por: Pallasch, Fabian Bernhard, et al.
Publicado: (2020)

Aqueous Humor TGF-β2 and Its Association With Intraocular Pressure in a Naturally Occurring Large Animal Model of Glaucoma
por: Oikawa, Kazuya, et al.
Publicado: (2023)

Effect of angiotensin II receptor blocker on TGF-β1, MMP-1, and collagen type I and type III concentration in New Zealand rabbit urethral stricture model
por: Siregar, Safendra, et al.
Publicado: (2018)

Genetic Variant of the Renin-Angiotensin System and Diabetes Influences Blood Pressure Response to Angiotensin Receptor Blockers
por: Konoshita, Tadashi, et al.
Publicado: (2009)

Immunohistochemical changes in rat retinas at various time periods of elevated intraocular pressure
por: Hernandez, María, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_g53n0l8nvlulpockg5r4u6aprg